Fortrea Holdings Inc. (FTRE)

NasdaqGS Currently down 0.04 (-0.22%) in today's trading session

1 member of Congress has disclosed 1 trade in Fortrea Holdings Inc. (FTRE) via STOCK Act filings. The most recent disclosure was a sale by J. French Hill on 23 June 2025. Aggregate disclosed activity totals roughly $8K in sales (midpoint estimates from bracketed disclosure amounts).

Fortrea Holdings Inc. is currently trading at $18.27, positioned at 76% of its 52-week range ($8.30 – $21.39).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$18.27
24h Change
-0.04 (-0.22%)
52 Week Range
$8.30$21.39
View on NASDAQ

Fortrea Holdings Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for FTRE

Select to highlight on chart
1 transactions
Compliance: 100%
J. French Hill23 Jun 202524 Jul 2025SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$1.74B

Volume

599.24K

Beta

1.97

P/E Ratio

32.62

Fundamentals

EPS

$0.56

Div. Yield

Open

$18.33

Day Range

$17.90 — $18.64

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Anshul Thakral
IPO Date
2023-06-20

Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinica...

Earnings

Next Report

Q3 2026

4 Nov

EPS Est.

$0.23

Rev. Est.

$670.5M

Days Until

70

Recent Quarters

Q2 202629 Jul
EPS$0.23
Beat 27.5%
Q1 20265 May
EPS$0.16
Beat 433.3%
Q4 202526 Feb
EPS$0.09
Miss 43.8%
Q3 20255 Nov
EPS$0.12
Miss 25.0%
Q2 20256 Aug
EPS$0.19
Beat 216.7%
Q1 202512 May
EPS$0.02
Beat 128.6%
Q4 20243 Mar
EPS$0.18
Miss 50.0%
Q3 20248 Nov
EPS$0.23
Miss 14.8%
Q2 202412 Aug
EPS$-0.03
Miss 142.9%
Q1 202413 May
EPS$-0.04
Miss 619.4%
Q4 202311 Mar
EPS$0.19
Miss 17.4%
Q3 202313 Nov
EPS$0.24
Beat 33.3%
Q2 202314 Aug
EPS$0.52
Beat 33.3%
Q1 20232 Jun
EPS$0.45
Beat 16.4%
Q3 202231 Dec
EPS$0.45
Q2 202230 Sept
EPS$0.69
Q1 202229 Jun
EPS$0.75
Q4 202130 Mar
EPS$0.37

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about FTRE

Which members of Congress have traded FTRE?
1 member of Congress has disclosed 1 trade in Fortrea Holdings Inc. (FTRE) under the STOCK Act: J. French Hill.
When was FTRE most recently disclosed by Congress?
The most recent FTRE disclosure was a sale by J. French Hill on 23 June 2025.
What is the total disclosed congressional trading volume for FTRE?
Members of Congress have disclosed approximately $8K in FTRE sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in FTRE?
This FTRE page updates as soon as new STOCK Act disclosures are filed for Fortrea Holdings Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.